DexCom (DXCM) Tops Q3 EPS by 45c, Raises FY Guidance
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.65, $0.45 better than the analyst estimate of $0.20. Revenue for the quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
